Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Observation of Patient and Caregiver Burden Associated with Early Alzheimer's Disease in the United States: Design and Baseline Findings of the GERAS-US Cohort Study1.

Robinson RL, Rentz DM, Bruemmer V, Scott Andrews J, Zagar A, Kim Y, Schwartz RL, Ye W, Fillit HM.

J Alzheimers Dis. 2019;72(1):279-292. doi: 10.3233/JAD-190430.

2.

Comparative STAT3-Regulated Gene Expression Profile in Renal Cell Carcinoma Subtypes.

Robinson RL, Sharma A, Bai S, Heneidi S, Lee TJ, Kodeboyina SK, Patel N, Sharma S.

Front Oncol. 2019 Feb 26;9:72. doi: 10.3389/fonc.2019.00072. eCollection 2019.

3.

Genetic epidemiology of malignant hyperthermia in the UK.

Miller DM, Daly C, Aboelsaod EM, Gardner L, Hobson SJ, Riasat K, Shepherd S, Robinson RL, Bilmen JG, Gupta PK, Shaw MA, Hopkins PM.

Br J Anaesth. 2018 Oct;121(4):944-952. doi: 10.1016/j.bja.2018.06.028. Epub 2018 Aug 17.

4.

Health Care Utilization and Direct Costs Among Patients Diagnosed with Cluster Headache in U.S. Health Care Claims Data.

Choong CK, Ford JH, Nyhuis AW, Robinson RL, Aurora SK.

J Manag Care Spec Pharm. 2018 Sep;24(9):921-928. doi: 10.18553/jmcp.2018.24.9.921.

5.

The Timed 180° Turn Test for Assessing People with Hemiplegia from Chronic Stroke.

Robinson RL, Ng SSM.

Biomed Res Int. 2018 Jan 15;2018:9629230. doi: 10.1155/2018/9629230. eCollection 2018.

6.

Increased Sensitivity of Diagnostic Mutation Detection by Re-analysis Incorporating Local Reassembly of Sequence Reads.

Watson CM, Camm N, Crinnion LA, Clokie S, Robinson RL, Adlard J, Charlton R, Markham AF, Carr IM, Bonthron DT.

Mol Diagn Ther. 2017 Dec;21(6):685-692. doi: 10.1007/s40291-017-0304-x.

7.

Clinical Characteristics and Treatment Patterns Among Patients Diagnosed With Cluster Headache in U.S. Healthcare Claims Data.

Choong CK, Ford JH, Nyhuis AW, Joshi SG, Robinson RL, Aurora SK, Martinez JM.

Headache. 2017 Oct;57(9):1359-1374. doi: 10.1111/head.13127. Epub 2017 Jun 5.

8.

Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population.

Hasin DS, Wall M, Witkiewitz K, Kranzler HR, Falk D, Litten R, Mann K, O'Malley SS, Scodes J, Robinson RL, Anton R; Alcohol Clinical Trials Initiative (ACTIVE) Workgroup.

Lancet Psychiatry. 2017 Jun;4(6):469-476. doi: 10.1016/S2215-0366(17)30130-X. Epub 2017 Apr 26.

9.

Anesthesia Case of the Month.

Robinson RL, Borer-Weir K.

J Am Vet Med Assoc. 2017 Jan 15;250(2):169-172. doi: 10.2460/javma.250.2.169. No abstract available.

PMID:
28058951
10.

Chimeric approach for narrowing a membrane-inserting region within human perforin.

Neely AE, Mandigo KA, Robinson RL, Ness TL, Weiland MH.

Protein Eng Des Sel. 2017 Feb;30(2):105-111. doi: 10.1093/protein/gzw069. Epub 2016 Dec 15.

PMID:
27980121
11.

Variations in the management of fibromyalgia by physician specialty: rheumatology versus primary care.

Able SL, Robinson RL, Kroenke K, Mease P, Williams DA, Chen Y, Wohlreich M, McCarberg BH.

Pragmat Obs Res. 2016 May 20;7:11-20. eCollection 2016.

12.

Clinical Impact of Not Achieving Recommended Dose on Duration of Atomoxetine Treatment in Adults with Attention-Deficit/Hyperactivity Disorder.

Clemow DB, Nyhuis AW, Robinson RL.

CNS Neurosci Ther. 2016 Dec;22(12):970-978. doi: 10.1111/cns.12595. Epub 2016 Jul 31.

13.

Using an FPLC to promote active learning of the principles of protein structure and purification.

Robinson RL, Neely AE, Mojadedi W, Threatt KN, Davis NY, Weiland MH.

Biochem Mol Biol Educ. 2017 Jan 2;45(1):60-68. doi: 10.1002/bmb.20980. Epub 2016 May 26.

14.

Covariates of depression and high utilizers of healthcare: Impact on resource use and costs.

Robinson RL, Grabner M, Palli SR, Faries D, Stephenson JJ.

J Psychosom Res. 2016 Jun;85:35-43. doi: 10.1016/j.jpsychores.2016.04.002. Epub 2016 Apr 13.

15.

After-Hours Call Center Triage of Pediatric Head Injury: Outcomes After a Concussion Initiative.

Fishe JN, Luberti AA, Master CL, Robinson RL, Grady MF, Arbogast KB, Zonfrillo MR.

Pediatr Emerg Care. 2016 Mar;32(3):149-53. doi: 10.1097/PEC.0000000000000724.

PMID:
26928093
16.

Vision Diagnoses Are Common After Concussion in Adolescents.

Master CL, Scheiman M, Gallaway M, Goodman A, Robinson RL, Master SR, Grady MF.

Clin Pediatr (Phila). 2016 Mar;55(3):260-7. doi: 10.1177/0009922815594367. Epub 2015 Jul 7.

PMID:
26156977
17.

A streamlined Western blot exercise: An efficient and greener approach in the laboratory classroom.

Ness TL, Robinson RL, Mojadedi W, Peavy L, Weiland MH.

Biochem Mol Biol Educ. 2015 Sep-Oct;43(5):358-65. doi: 10.1002/bmb.20876. Epub 2015 Jul 7.

18.

Impact of non-remission of depression on costs and resource utilization: from the COmorbidities and symptoms of DEpression (CODE) study.

Dennehy EB, Robinson RL, Stephenson JJ, Faries D, Grabner M, Palli SR, Stauffer VL, Marangell LB.

Curr Med Res Opin. 2015 Jun;31(6):1165-77. doi: 10.1185/03007995.2015.1029893. Epub 2015 May 12.

PMID:
25879140
19.

Correction: Genotoxicity of metal oxide nanomaterials: review of recent data and discussion of possible mechanisms.

Golbamaki N, Rasulev B, Cassano A, Robinson RL, Benfenati E, Leszczynski J, Cronin MT.

Nanoscale. 2015 Apr 14;7(14):6388. doi: 10.1039/c5nr90036k. No abstract available.

PMID:
25776996
20.

Vestibular Deficits following Youth Concussion.

Corwin DJ, Wiebe DJ, Zonfrillo MR, Grady MF, Robinson RL, Goodman AM, Master CL.

J Pediatr. 2015 May;166(5):1221-5. doi: 10.1016/j.jpeds.2015.01.039. Epub 2015 Mar 5.

21.

Hospitalist workload influences faculty evaluations by internal medicine clerkship students.

Robinson RL.

Adv Med Educ Pract. 2015 Feb 10;6:93-8. doi: 10.2147/AMEP.S77216. eCollection 2015.

22.

The importance of unresolved fatigue in depression: costs and comorbidities.

Robinson RL, Stephenson JJ, Dennehy EB, Grabner M, Faries D, Palli SR, Swindle RW.

Psychosomatics. 2015 May-Jun;56(3):274-85. doi: 10.1016/j.psym.2014.08.003. Epub 2014 Aug 20.

23.

Characteristics of prolonged concussion recovery in a pediatric subspecialty referral population.

Corwin DJ, Zonfrillo MR, Master CL, Arbogast KB, Grady MF, Robinson RL, Goodman AM, Wiebe DJ.

J Pediatr. 2014 Dec;165(6):1207-15. doi: 10.1016/j.jpeds.2014.08.034. Epub 2014 Sep 26.

24.

Long-term evaluation of opioid treatment in fibromyalgia.

Peng X, Robinson RL, Mease P, Kroenke K, Williams DA, Chen Y, Faries D, Wohlreich M, McCarberg B, Hann D.

Clin J Pain. 2015 Jan;31(1):7-13. doi: 10.1097/AJP.0000000000000079.

PMID:
24480913
25.

Tablet computer use by medical students in the United States.

Robinson RL, Burk MS.

J Med Syst. 2013 Aug;37(4):9959. doi: 10.1007/s10916-013-9959-y. Epub 2013 Jul 7.

PMID:
23832806
26.

Longitudinal observation of treatment patterns and outcomes for patients with fibromyalgia: 12-month findings from the reflections study.

Robinson RL, Kroenke K, Williams DA, Mease P, Chen Y, Faries D, Peng X, Hann D, Wohlreich M, McCarberg B.

Pain Med. 2013 Sep;14(9):1400-15. doi: 10.1111/pme.12168. Epub 2013 Jun 11.

27.

Cognitive rest and school-based recommendations following pediatric concussion: the need for primary care support tools.

Arbogast KB, McGinley AD, Master CL, Grady MF, Robinson RL, Zonfrillo MR.

Clin Pediatr (Phila). 2013 May;52(5):397-402. doi: 10.1177/0009922813478160. Epub 2013 Feb 27.

PMID:
23447397
28.

Burden of illness and treatment patterns for patients with fibromyalgia.

Robinson RL, Kroenke K, Mease P, Williams DA, Chen Y, D'Souza D, Wohlreich M, McCarberg B.

Pain Med. 2012 Oct;13(10):1366-76. doi: 10.1111/j.1526-4637.2012.01475.x. Epub 2012 Sep 7.

PMID:
22958298
29.

Hierarchical virtual screening for the discovery of new molecular scaffolds in antibacterial hit identification.

Ballester PJ, Mangold M, Howard NI, Robinson RL, Abell C, Blumberger J, Mitchell JB.

J R Soc Interface. 2012 Dec 7;9(77):3196-207. doi: 10.1098/rsif.2012.0569. Epub 2012 Aug 29.

30.

Influencing hospitalist clinical productivity with feedback.

Robinson RL, Burk MS.

J Med Pract Manage. 2012 Mar-Apr;27(5):301-4.

PMID:
22594065
31.

The challenges involved in modeling toxicity data in silico: a review.

Gleeson MP, Modi S, Bender A, Robinson RL, Kirchmair J, Promkatkaew M, Hannongbua S, Glen RC.

Curr Pharm Des. 2012;18(9):1266-91. Review.

PMID:
22316153
32.

A portable instrument for high-speed brain function imaging: FEITER.

McCann H, Ahsan ST, Davidson JL, Robinson RL, Wright P, Pomfrett CJ.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:7029-32. doi: 10.1109/IEMBS.2011.6091777.

PMID:
22255957
33.

Virtual design of chemical penetration enhancers for transdermal drug delivery.

Golla S, Neely BJ, Whitebay E, Madihally S, Robinson RL Jr, Gasem KA.

Chem Biol Drug Des. 2012 Apr;79(4):478-87. doi: 10.1111/j.1747-0285.2011.01293.x.

34.

Incidence and impact of pain conditions and comorbid illnesses.

Davis JA, Robinson RL, Le TK, Xie J.

J Pain Res. 2011;4:331-45. doi: 10.2147/JPR.S24170. Epub 2011 Oct 10.

35.

The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disorders.

Anton RF, Litten RZ, Falk DE, Palumbo JM, Bartus RT, Robinson RL, Kranzler HR, Kosten TR, Meyer RE, O'Brien CP, Mann K, Meulien D.

Neuropsychopharmacology. 2012 Jan;37(2):402-11. doi: 10.1038/npp.2011.182. Epub 2011 Sep 7.

36.

Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder.

Ye W, Zhao Y, Robinson RL, Swindle RW.

BMC Psychiatry. 2011 Jan 31;11:19. doi: 10.1186/1471-244X-11-19.

37.
38.

The role of CACNA1S in predisposition to malignant hyperthermia.

Carpenter D, Ringrose C, Leo V, Morris A, Robinson RL, Halsall PJ, Hopkins PM, Shaw MA.

BMC Med Genet. 2009 Oct 13;10:104. doi: 10.1186/1471-2350-10-104.

39.

Design of improved permeation enhancers for transdermal drug delivery.

Godavarthy SS, Yerramsetty KM, Rachakonda VK, Neely BJ, Madihally SV, Robinson RL Jr, Gasem KA.

J Pharm Sci. 2009 Nov;98(11):4085-99. doi: 10.1002/jps.21940.

PMID:
19697392
40.

Genetic variation in RYR1 and malignant hyperthermia phenotypes.

Carpenter D, Robinson RL, Quinnell RJ, Ringrose C, Hogg M, Casson F, Booms P, Iles DE, Halsall PJ, Steele DS, Shaw MA, Hopkins PM.

Br J Anaesth. 2009 Oct;103(4):538-48. doi: 10.1093/bja/aep204. Epub 2009 Jul 31.

41.

A RYR1 mutation associated with recessive congenital myopathy and dominant malignant hyperthermia in Asian families.

Carpenter D, Ismail A, Robinson RL, Ringrose C, Booms P, Iles DE, Halsall PJ, Steele D, Shaw MA, Hopkins PM.

Muscle Nerve. 2009 Oct;40(4):633-9. doi: 10.1002/mus.21397.

PMID:
19645060
42.

Comparison of health care use and costs in newly diagnosed and established patients with fibromyalgia.

White LA, Robinson RL, Yu AP, Kaltenboeck A, Samuels S, Mallett D, Birnbaum HG.

J Pain. 2009 Sep;10(9):976-83. doi: 10.1016/j.jpain.2009.03.012. Epub 2009 Jun 24.

PMID:
19556168
43.

Parental depression as a moderator of secondary deficits of depression in adult offspring.

Timko C, Cronkite RC, Swindle R, Robinson RL, Sutkowi A, Moos RH.

Child Psychiatry Hum Dev. 2009 Dec;40(4):575-88. doi: 10.1007/s10578-009-0145-x. Epub 2009 May 20.

PMID:
19455416
44.

Epigenetic allele silencing and variable penetrance of malignant hyperthermia susceptibility.

Robinson RL, Carpenter D, Halsall PJ, Iles DE, Booms P, Steele D, Hopkins PM, Shaw MA.

Br J Anaesth. 2009 Aug;103(2):220-5. doi: 10.1093/bja/aep108. Epub 2009 May 19.

45.

Nonlinear quantitative structure-property relationship modeling of skin permeation coefficient.

Neely BJ, Madihally SV, Robinson RL Jr, Gasem KA.

J Pharm Sci. 2009 Nov;98(11):4069-84. doi: 10.1002/jps.21678.

46.

A study of composite electrode-tissue impedance.

Robinson RL, Davidson JL, Wright P, Pomfrett CJ, McCann H.

Conf Proc IEEE Eng Med Biol Soc. 2008;2008:1171-4. doi: 10.1109/IEMBS.2008.4649370.

PMID:
19162873
47.

Quantitative structure-property relationship modeling of skin sensitization: a quantitative prediction.

Golla S, Madihally S, Robinson RL Jr, Gasem KA.

Toxicol In Vitro. 2009 Apr;23(3):454-65. doi: 10.1016/j.tiv.2008.12.025. Epub 2009 Jan 8.

PMID:
19162165
48.

Quantitative structure-property relationships modeling of skin irritation.

Golla S, Madihally S, Robinson RL Jr, Gasem KA.

Toxicol In Vitro. 2009 Feb;23(1):176-84. doi: 10.1016/j.tiv.2008.10.013. Epub 2008 Nov 5.

PMID:
19027061
49.

Analysis of RYR1 haplotype profile in patients with malignant hyperthermia.

Carpenter D, Morris A, Robinson RL, Booms P, Iles D, Halsall PJ, Steele D, Hopkins PM, Shaw MA.

Ann Hum Genet. 2009 Jan;73(1):10-8. doi: 10.1111/j.1469-1809.2008.00482.x. Epub 2008 Oct 15.

50.

Malignant hyperthermia and associated conditions.

Halsall PJ, Robinson RL.

Handb Clin Neurol. 2007;86:107-24. doi: 10.1016/S0072-9752(07)86005-2. No abstract available.

PMID:
18808997

Supplemental Content

Loading ...
Support Center